Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Clearance rates of total prostate specific antigen (PSA) after radical prostatectomy in African-Americans and Caucasians

Abstract

Racial differences in serum prostate specific antigen (PSA) values in men with and without prostate cancer have been observed but have yet to be explained. We aimed to determine if ethnic variations in the rate of metabolism of PSA could explain the different levels of PSA found in African-American and Caucasian men. In a prospective fashion, patients diagnosed with biopsy-proven clinically localized adenocarcinoma of the prostate and scheduled for radical prostatectomy were selected for the study. Eleven patients (six Caucasian, five African-American) were enrolled in the study. All patients demonstrated normal liver and renal function. Sera for total PSA were obtained at the following time intervals: preoperative (within 3 months of operation), time 0 (at time of prostate removal), 1, 4, 8, 24, 48, 72, 168 and 336 h after removal of the prostate. A log–linear regression model was then used to determine the metabolic clearance rate and half-life of serum total PSA. There were no statistically significant differences between Caucasian and African-American patients with regard to age, PSA prior to surgery, prostate weight, Gleason sum and PSA half-life. The metabolic clearance of total PSA followed first order kinetics. When comparing serum PSA levels expressed as a fraction of the baseline PSA, Caucasian and African-American patients demonstrated similar rates of metabolism. This study found similar rates of elimination of serum total PSA between African-Americans and Caucasians. These findings suggest that the rate of metabolism of PSA is similar for these groups. Further studies are needed to explain racial differences of serum PSA in patients with and without prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Powell IJ . Prostate cancer in the African-American: is this a different disease? Semin Urol Oncol 1998 16: 221–226

    CAS  PubMed  Google Scholar 

  2. Freedland SJ et al. Clinical characteristics in black and white men with prostate cancer in an equal access medical center Urology 2000 55: 387–390

    Article  CAS  PubMed  Google Scholar 

  3. Moul JW et al. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients J Urol 1999 162: 394–397

    Article  CAS  PubMed  Google Scholar 

  4. Moul JW et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men JAMA 1995 274: 1277–1281

    Article  CAS  PubMed  Google Scholar 

  5. Morgan TO et al. Age-specific reference ranges for prostate-specific antigen in black men New Engl J Med 1996 335: 304–310

    Article  CAS  PubMed  Google Scholar 

  6. Pettaway CA et al. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens J Urol 1998 160: 437–442

    Article  CAS  PubMed  Google Scholar 

  7. Polascik TJ, Oesterling JE, Partin AW . Prostate specific antigen: a decade of discovery—what we have learned and where we are going J Urol 1999 162: 293–306

    Article  CAS  PubMed  Google Scholar 

  8. Stamey TA et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate New Engl J Med 1987 317: 909–916

    Article  CAS  PubMed  Google Scholar 

  9. Oesterling JE et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy J Urol 1988 139: 766–772

    Article  CAS  PubMed  Google Scholar 

  10. Partin AW et al. Clearance rate of serum-free and total PSA following radical retropubic prostatectomy Prostate 1996 7: (Suppl) 35–39

    Article  CAS  Google Scholar 

  11. Bjork T et al. Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum Urology 1998 51: 57–62

    Article  CAS  PubMed  Google Scholar 

  12. Stephan C et al. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation Urology 2000 55: 560–563

    Article  CAS  PubMed  Google Scholar 

  13. Ravery V, Meulemans A, Boccon-Gibod L . Clearance of free and total serum PSA after prostatic surgery Eur Urol 1998 33: 251–254

    Article  CAS  PubMed  Google Scholar 

  14. Agha AH et al. Prostate specific antigen is metabolized in the liver J Urol 1996 155: 1332–1335

    Article  CAS  PubMed  Google Scholar 

  15. Kilic S et al. Determination of the site of metabolism of total, free, and complexed prostate-specific antigen Urology 1998 52: 470–473

    Article  CAS  PubMed  Google Scholar 

  16. Birkenmeier G, Struck F, Gebhardt R . Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin J Urol 1999 162: 897–901

    Article  CAS  PubMed  Google Scholar 

  17. Ross RK et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males Lancet 1992 339: 887–889

    Article  CAS  PubMed  Google Scholar 

  18. Vijayakumar S et al. Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer J Natl Med Assoc 1995 87: 813–819

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Irvine RA et al. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer Cancer Res 1995 55: 1937–1940

    CAS  PubMed  Google Scholar 

  20. Moul JW et al. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting J Urol 1996 155: 1667–1673

    Article  CAS  PubMed  Google Scholar 

  21. Powell IJ et al. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins Urology 1997 49: 726–731

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C G Roehrborn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lotan, Y., Roehrborn, C. Clearance rates of total prostate specific antigen (PSA) after radical prostatectomy in African-Americans and Caucasians. Prostate Cancer Prostatic Dis 5, 111–114 (2002). https://doi.org/10.1038/sj.pcan.4500567

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500567

Keywords

This article is cited by

Search

Quick links